Skip to main content
. Author manuscript; available in PMC: 2011 Oct 21.
Published in final edited form as: Neurobiol Aging. 2010 Jun 8;31(8):1326–1339. doi: 10.1016/j.neurobiolaging.2010.04.006

Table 2. Subject demographics and neuropsychiatric characteristics for the CHS-CS.

The mean ± s.d. is shown for the following variables: age, education, BMI, MMSE, and Sum-of-boxes CDR.

AD (n=36) MCI (n=77)
Age 81.9±5.2* 79.8±4.3*
Sex (Male) 12 39
Ethnicity: White 27 61
     Black 11 20
     Other 0 0
Education (>high school) 41.7% 53.2%
Apoe4 23.30%** 27.50%**
BMI 25.5±5.1 26.1±4.0
3MSE 77.7±13.3 90.0±6.6
DSST 26.6±12.9 36.3±12.4
*

An ANOVA was performed on the variable age only to determine whether the mean age differed significantly between ADNI and CHS groups. The average age was different between ADNI and CHS groups for the AD patients (F1,222 =24.5; P=1.468 × 10−6), and for the MCI patients (F1,474=32.2; P=2.404 × 10−8).

**

A chi-squared test was performed for the categorical variable, presence of ApoE4; the subscript indicates the number of degrees of freedom. The incidence of the ApoE4 allele was different between ADNI and CHS groups in AD patients (χ21 = 18.8; P =1.456 × 10−5) and MCI patients (χ21=15.9; P =6.5 × 10−5).

HHS Vulnerability Disclosure